Back to MLTX
T. Rowe Price Investment Management, Inc. → MLTX
T. Rowe Price Investment Management, Inc. MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
4
Latest value
$61.1M
Q3 2026
Peak value
$83.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $47K |
| Q4 2025 | $47K |
| Q2 2026 | $83.3M |
| Q3 2026 | $61.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $61.1M | 5.22M | — | — |
| Q2 2026 | $83.3M | 4.28M | — | — |
| Q4 2025 | $47K | 3.6K | — | — |
| Q4 2025 | $47K | 3.6K | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M